Horizon Therapeutics Public Limited Company (HZNP) financial statements (2022 and earlier)

Company profile

Business Address CONNAUGHT HOUSE, 1ST FLOOR
DUBLIN, 4
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,5802,0801,076959751509
Cash and cash equivalents1,5802,0801,076959751509
Restricted cash and investments444377
Receivables633660409465367306
Inventory, net of allowances, customer advances and progress billings22675545162175
Inventory22675545162175
Prepaid expense  136 26
Advances on inventory purchases16013831   
Other undisclosed current assets197114100654323
Total current assets:2,8003,0701,6861,5481,2301,046
Noncurrent Assets
Operating lease, right-of-use asset  40
Property, plant and equipment29218930202023
Intangible assets, net (including goodwill)1,0672,1972,1162,5522,8763,219
Goodwill1,067414414426426446
Intangible assets, net (excluding goodwill) 1,7831,7032,1252,4492,773
Deferred income tax assets53856118
Other noncurrent assets141564823362
Other undisclosed noncurrent assets3,840 497331
Total noncurrent assets:5,8783,0022,7502,5982,9363,246
TOTAL ASSETS:8,6786,0734,4364,1464,1664,292
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities553523257236173235
Accounts payable303822303552
Accrued liabilities523486235206138183
Debt16 4 118
Liability for uncertainty in income taxes  22  
Deferred revenue and credits73
Other undisclosed current liabilities317352460524567360
Total current liabilities:887876723762757606
Noncurrent Liabilities
Long-term debt and lease obligation  1,3991,8971,8911,800
Long-term debt, excluding current maturities  1,3531,8971,8911,800
Operating lease, liability  47
Liabilities, other than long-term debt564168102167249361
Deferred revenue and credits108
Deferred compensation liability, classified  13873
Deferred tax liabilities, net94158297
Deferred income tax liabilities39066 
Liability for uncertainty in income taxes  91068
Other liabilities17310280556846
Other undisclosed noncurrent liabilities2,5551,00326267278261
Total noncurrent liabilities:3,1191,1721,5272,3302,4182,422
Total liabilities:4,0052,0472,2513,0923,1753,028
Stockholders' equity
Stockholders' equity attributable to parent4,6724,0252,1851,0549911,264
Common stock000000
Treasury stock, value(5)(5)(5)(5)(5)(5)
Additional paid in capital4,3734,2462,7982,3752,2492,119
Accumulated other comprehensive loss(15)(0)(2)(2)(1)(3)
Retained earnings (accumulated deficit)319(216)(606)(1,315)(1,252)(848)
Total stockholders' equity:4,6724,0252,1851,0549911,264
TOTAL LIABILITIES AND EQUITY:8,6786,0734,4364,1464,1664,292

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues3,2262,2001,3001,2081,056981
Revenue, net1,056981
Cost of revenue
(Cost of Goods and Services Sold)
(795)(533)(362)(422)(546)(393)
Gross profit:2,4321,668938785510588
Operating expenses(1,889)(1,178)(811)(783)(902)(735)
Operating income (loss):5434901272(392)(147)
Nonoperating expense(80)(88)(147)(122)(121)(81)
Interest and debt expense (32)(59)   
Other undisclosed income from continuing operations before equity method investments, income taxes 3259   
Income (loss) from continuing operations before equity method investments, income taxes:463402(20)(119)(513)(228)
Income from equity method investments 1    
Other undisclosed loss from continuing operations before income taxes (1)    
Income (loss) from continuing operations before income taxes:463402(20)(119)(513)(228)
Income tax expense (benefit)72(12)5934510361
Net income (loss) available to common stockholders, basic:534390573(74)(411)(167)
Dilutive securities, effect on basic earnings per share534390595   
Net income (loss) available to common stockholders, diluted:1,0697801,168(74)(411)(167)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):534390573(74)(411)(167)
Other comprehensive income (loss)(15)2(0)(1)2(0)
Comprehensive income (loss), net of tax, attributable to parent:520392573(75)(408)(167)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: